Immunohistochemical staining for ganglioside GD1b as a diagnostic and prognostic marker for primary human brain tumors

Neuro-Oncology

Volumn 1, Issue 4, 1999, Pages 261-267

  Comas, Theodore C ^a   Tai, Tadashi ^b   Kimmel, David ^c   Scheithauer, Bernd W ^c   Burger, Peter C ^d   Pearl, Dennis K ^a   Jewell, Scott D ^a   Yates, Allan J ^a,e  

^a OHIO STATE UNIVERSITY   (United States)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c MAYO CLINIC   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e Division of Neuropathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE, GD1B; TUMOR MARKER;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CARBOHYDRATE ANALYSIS; CHEMISTRY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; EVALUATION; HUMAN; LIFE TABLE; MOLECULAR GENETICS; MORTALITY; NEUROECTODERM TUMOR; OLIGODENDROGLIOMA; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; SURVIVAL;

ASTROCYTOMA; BRAIN NEOPLASMS; CARBOHYDRATE SEQUENCE; GANGLIOSIDES; HUMANS; IMMUNOENZYME TECHNIQUES; LIFE TABLES; MOLECULAR SEQUENCE DATA; NEUROECTODERMAL TUMORS, PRIMITIVE; OLIGODENDROGLIOMA; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033206946     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1093/neuonc/1.4.261     Document Type: Article

References (24)

1. Berra, B., Gaini, S.M., and Riboni, L. (1985) Correlation between ganglioside distribution and histological grading of human astrocytomas. Int. J. Cancer 36, 363-366.
2. Chester, M.A. (1998) IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of glycolipids. Recommendations 1997. Eur. J. Biochem. 257, 293-298.
3. Daumas-Duport, C. (1992) Histological grading of gliomas. Current Opin. Neurol. Neurosurg. 5, 924-931.
4. Daumas-Duport, C., Scheithauer, B., O'Fallon, J., and Kelly, P. (1988) Grading of astrocytomas: A simple and reproducible method. Cancer 62, 2152-2165.
5. El-Abbadi, M., and Seyfried, T.N. (1994) Influence of growth environment on the ganglioside composition of an experimental mouse brain tumor. Mol. Chem. Neuropathol. 21, 273-285.
6. Finlay, J.L., Boyett, J.M., Yates, A.J., Wisoff, J.H., Milstein, J.M., Geyer, J.R., Bertolone, S.J., McGuire, P., Cherlow, J.M., Tefft, M., Turski, P.A., Wara, W.M., Edwards, M., Sutton, L.N., Berger, M.S., Epstein, F., Ayers, G., Allen, J.C., Packer, R.J. (1995) Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. J.Clin.Oncol. 13, 112-123.
7. Fredman, P., von Holst, H., Collins, V.P., Granholm, L., and Svennerholm, L. (1988) Siallyllactotetraosylceramide, a ganglioside marker for human malignant gliomas. J. Neurochem. 50, 912-919.
8. Jennemann, R., Rodden, A., Bauer, B.L., Mennel, H.D., and Wiegandt, H. (1990) Glycosphingolipids of human gliomas. Cancer Res. 50, 7444-7449.
9. Kernohan, J.W., Mabon, R.F., Svien, H.J., Adson, A.W. (1949) A simplified classification of the gliomas. Mayo Clinic Proc. 24, 71-74.
10. Kleihues, P., Burger, P.C., and Scheithauer, B.W. (1993) Histological Typing of Tumours of the Central Nervous System. International Histological Classification of Tumours, World Health Organization. Second edition. New York: Springer-Verlag.
11. Kostic, D., and Bucheit, F. (1970) Gangliosides in human brain tumors. Life Sci. (Pt. 2) 9, 589-596.
12. Ledeen, R.W., and Yu, R.K. (1982) Gangliosides: Structure, isolation, and analysis. Methods Enzymol. 83, 139-191.
13. Ledeen, R.W., Yu, R.K., and Eng, L.F. (1973) Gangliosides of human myelin: Sialosylgalactosylceramide (G7) as a major component. J. Neurochem. 21, 829-839.
14. Ozawa, H., Kotani, M., Kawashima, I., and Tai, T. (1992) Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides. Biochim. Biophys. Acta 1123, 184-190.
15. Ringertz, N. (1949) Grading of gliomas. Acta Pathol. Microbiol. Scand. 27, 51-64.
16. Ross, G.W., and Rubinstein, L.J. (1989) Lack of histopathological correlation of malignant ependymomas with postoperative survival. J. Neurosurg. 70, 31-36.
17. Segler-Stahl, K., Webster, J.C., and Brunngraber, E.G. (1983) Changes in the concentration and composition of human brain gangliosides with aging. Gerontology 29, 161-168.
18. Seyfried, T.N., El-Abbadi, M., Ecsedy, J.A., Bai, H.W., and Yohe, H.C. (1996) Influence of host cell infiltration on the glycolipid content of mouse brain tumors. J. Neurochem. 66, 2026-2033.
19. Sung, C.C., Pearl, D.K., and Yates, A.J. (1993) Ganglioside composition of human brain tumors. J. Neurochem. 61, S232.
20. Sung, C.C., Pearl, D.K., Coons, S.W., Scheithauer, B.W., Johnson, P.C., and Yates, A.J. (1994) Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors. Cancer 74, 3010-3022.
21. Svennerholm, L. (1980) Ganglioside designation. Adv. Exp. Med. Biol. 125, 11.
22. Traylor, T.D., and Hogan, E.L. (1980) Gangliosides of human cerebral astrocytomas. J. Neurochem. 34, 126-131.
23. Vanier, M.T., Holm, M., Ohman, R., and Svennerholm, L. (1971) Developmental profiles of gangliosides in human and rat brain. J. Neurochem. 18, 581-592.
24. Wiegandt, H. (1982) The gangliosides. In Agranoff, B.W., and Aprison, M.H. (Eds.), Advances in Neurochemistry, Vol. 4. New York: Plenum Press. pp. 149-223.